stroke: treating LDL to target
A new article from last week's Am Heart Assn meetings found that treating LDL to a lower target led to fewer subsequent cardiovasc events in those with TIA/ischemic stroke (see stroke LDL target nejm2019 in dropbox, or DOI: 10.1056/NEJMoa1910355) Details: --2860 patients with evidence of atherosclerotic disease, having had ischemic stroke in prior 3 months or TIA in the previous 15 days, were randomized to a target LDL of <70 mg/dL vs 90-110mg/dL, using adjustable doses of statins with ezetimibe as needed, in the Treat Stroke to Target trial from France (61 sites) and South Korea (16 sites) -- ischemic stroke was defined as symptoms with documented ischemic lesion on CT or MRI; TIAs had to be a motor deficit in one arm or leg, or speech disturbance >10 minutes --all patients were screened with nonivasive imaging (carotid duplex, CT angiography, and MR angiography) per the AHA-ASA...